Skip to main content
. 2023 Apr 18;21(5):125–129. doi: 10.1097/CLD.0000000000000033

FIGURE 1.

FIGURE 1

Approach to selecting initial alcohol use disorder pharmacotherapy option in alcohol-associated liver disease. This algorithm represents the authors best synthesis of AUD-focused and ALD-focused society guideline recommendations for AUD pharmacotherapy in the ALD population, it is intended as a reference only and has not been validated or tested in clinical practice. *Adjust dose for renal function. Use with caution in HE. Abbreviation: CrCl, creatinine clearance.